CRC is a specialist provider of consulting, research and data for health outcomes and health economics groups in the UK NHS, leading pharmaceutical companies and reimbursers.
Following its acquisition by healthcare research and benchmarking consultancy CHKS, CRC now has access to over 150 million detailed patient records. The scale of its database, combined with CRC staffs’ combined 100 years’ experience of analysing and interpreting data adds genuine value to the needs of the NHS and pharmaceutical companies.
Our service focuses entirely on providing robust and timely HTA solutions using unrivalled patient level data.
We are able to do this by leveraging our industry and research experience in health economics, disease modelling and applied statistical data analysis; aligned to the world’s premiere health outcomes data resources, the CHKS and Health Outcomes Data Repository (HODaR) databases.
Our track record includes over 100 disease reports across 50 disease areas; 30 economic models covering 22 disease areas and 18 reimbursement appraisals covering 12 pharmaceutical products in 4 countries.
CRC’s role is to help our clients understand disease burden across primary and secondary care providing superior information for decision making.
CRC’s longitudinal healthcare databases include over 150 million secondary care patient records linked for up to 15 years enabling comprehensive burden of illness studies.
Additionally, the Health Outcomes Data Repository (HODaR) contains SF36, SF12, EQ5D and detailed resource usage information linked to over 60,000 patient records across seven centres in the UK.